1. Home
  2. FEMY vs TPCS Comparison

FEMY vs TPCS Comparison

Compare FEMY & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.50

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

HOLD

Current Price

$3.60

Market Cap

34.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEMY
TPCS
Founded
2004
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
34.0M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
FEMY
TPCS
Price
$0.50
$3.60
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
442.0K
59.7K
Earning Date
05-07-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
8.60
64.20
EPS
N/A
N/A
Revenue
$1,629,108.00
$34,031,000.00
Revenue This Year
$59.47
N/A
Revenue Next Year
$150.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
51.97
7.72
52 Week Low
$0.31
$2.08
52 Week High
$1.63
$6.25

Technical Indicators

Market Signals
Indicator
FEMY
TPCS
Relative Strength Index (RSI) 41.82 39.89
Support Level $0.48 $3.23
Resistance Level $0.58 $3.85
Average True Range (ATR) 0.04 0.26
MACD -0.00 0.03
Stochastic Oscillator 12.87 41.07

Price Performance

Historical Comparison
FEMY
TPCS

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About TPCS TechPrecision Corporation

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

Share on Social Networks: